Putting the award page together from the records…
Putting the award page together from the records…
The Charles Stark Draper Laboratory, Inc. received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $45.86M obligated so far for health r&d services; health care services; experimental development. It runs to 2028-09-28.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75A50123C00042, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75A50123C00042_7505_-NONE-_-NONE-
The Charles Stark Draper Laboratory, Inc.: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys · The follow-on: recompete brief
ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC
Up for re-bid: ends 2028-09-28. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
7 subawards totaling $2.54M (5.5% of what was obligated), as The Charles Stark Draper Laboratory, Inc. reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Trustees of Boston University | $2.02M | 1 | MA | 2024-12-23 | 2024-12-23 |
| L & Z Tool & Engineering Inc | $290.0K | 2 | NJ | 2025-01-13 | 2025-12-11 |
| Battelle Memorial Institute | $125.0K | 1 | WA | 2023-12-06 | 2023-12-06 |
| Bio-Techne Corp | $66.6K | 2 | MN | 2025-02-04 | 2025-05-15 |
| Sapient Bioanalytics, LLC | $43.6K | 1 | CA | 2026-02-25 | 2026-02-25 |
| Date | To | Amount | For |
|---|---|---|---|
| 2024-12-23 | Trustees of Boston University | $2.02M | COMPANY WILL PROVIDE DRAPER WITH TECHNICAL SUPPORT FOR PROGRAM. |
| 2025-12-11 | L & Z Tool & Engineering Inc | $155.0K | COMPANY WILL PROVIDE DRAPER WITH TECHNICAL SUPPORT FOR PROGRAM. |
| 2025-01-13 | L & Z Tool & Engineering Inc | $135.0K | COMPANY WILL PROVIDE DRAPER WITH TECHNICAL SUPPORT FOR PROGRAM. |
| 2023-12-06 | Battelle Memorial Institute | $125.0K | COMPANY WILL PROVIDE DRAPER WITH TECHNICAL SUPPORT FOR PROGRAM. |
| 2026-02-25 | Sapient Bioanalytics, LLC | $43.6K | COMPANY WILL PROVIDE DRAPER WITH TECHNICAL SUPPORT FOR PROGRAM. |
| 2025-02-04 | Research and Diagnostic Systems, Inc | $35.9K | COMPANY WILL PROVIDE DRAPER WITH TECHNICAL SUPPORT FOR PROGRAM. |
| 2025-05-15 | Research and Diagnostic Systems, Inc | $30.6K | COMPANY WILL PROVIDE DRAPER WITH TECHNICAL SUPPORT FOR PROGRAM. |
8 actions since 2023-09-29. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-03 | P00007 | Option exercised | $9.82M | THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO: (1) EXERCISE AND FUND CLIN 0015/OPTION 13 AND CLIN 0017/OPTION 15; (2) PROVIDE SUPPLEMENTAL FUNDING FOR CLIN 0016/OPTION 14; (3) REVISE ARTICLE IV, MANAGEMENT OF THE PROGRAM, TO UPDATE THE RECIPIENT/G |
| 2026-05-27 | P00006 | Administrative change | $0 | NO COST ADMINISTRATIVE MOD TO REVISE SECTION - ARTICLE VI: COST PLUS FIXED FEE, WITH UPDATED DCMA INDIRECT RATES. |
| 2025-12-17 | P00005 | Administrative change | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING:: NO COST MODIFICATION TO REVISE BUDGET AND FUNDING AMOUNTS FOR CLIN 0009 AND CLIN 0010. |
| 2025-09-25 | P00004 | Option exercised | $1.28M | EXERCISE CLIN0016/OPTION 14 AND REVISE THE STATEMENT OF WORK. |
| 2024-11-06 | P00003 | Administrative change | $0 | THE PURPOSE OF THIS NO COST MOD IS TO REVISE ARTICLE IV: MANAGEMENT OF THE PROGRAM, A. RECIPIENT/GOVERNMENT JOINT OVERSIGHT COMMITTEE, NON-VOTING ATTENDEES. |
| 2024-09-26 | P00002 | Additional work (new agreement) | $8.10M | ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC |
| 2024-01-25 | P00001 | Administrative change | $0 | ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC |
| 2023-09-29 | 0 | $26.66M | ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗